The Lead Episode 114: A Discussion of Lifestyle and risk factor modification in atrial fibrillation - A European Heart Rhythm Association survey LIVE from Heart Rhythm 2025 in San Diego

Description

Melissa E. Middeldorp, MPH, PhD is joined by Thomas F. Deering, BS, MBA, MD, FHRS, CCDS, and T. Jared Bunch, MD, FHRS to discuss a 31-item questionnaire was developed and distributed among healthcare professionals via the EHRA network and social media between 23 September and 21 October 2024.

Learning Objectives

Identify the key lifestyle and modifiable risk factors associated with the development and progression of atrial fibrillation (AF).
Understand current clinical practices and attitudes among European healthcare professionals regarding lifestyle interventions in AF management.
Evaluate the gaps between evidence-based recommendations and real-world implementation of lifestyle and risk factor modifications in AF care.

Article Authors and Podcast Contributors

Article Authors

Mark T Mills , Piotr Futyma , Peter Calvert , Diego Penela , Laurent Roten , Laura Perrotta , Federico Migliore , Gregory Y H Lip , Dhiraj Gupta , Julian K R Chun

Podcast Contributors

Melissa E. Middeldorp, MPH, PhD, University of Adelaide
Thomas F. Deering, BS, MBA, MD, FHRS, CCDS, Piedmont Heart Institute
T. Jared Bunch, MD, FHRS, University of Utah School of Medicine

Faculty and Disclosures

All relevant financial relationships have been mitigated.

Host Disclosure(s):

M. Middeldorp:

Nothing to disclose.

Contributor Disclosure(s):

T. Deering:

Honoraria/Speaking/Consulting: Sanofi, Pacemate, Pfizer, Inc., Omny Health, Preventice
Research: Abbott, Boston Scientific, Medtronic, Biotronik, Biosense Webster, Inc.,
Stock Options - Privately Held: HeartBeam
Officer, Trustee, Director, Committee Chair: Board Membership

T. Bunch

Honoraria/Speaking/Consulting: Pfizer, Inc. Heart Rhythm Society

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):

S. Sailor: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.

Summary

Availability:

On-Demand

Cost:

FREE

Credit Offered:

No Credit Offered